Ultragenyx Pharmaceutical (RARE) Return on Equity [ROE] (2014 - 2025)
Ultragenyx Pharmaceutical (RARE) posted Return on Equity [ROE] of -657.14% for FY2025, down 442.43 percentage points from -214.72% in FY2024.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Return on Equity [ROE] (2014 - 2025) Analysis & Trends
Since FY2014, Ultragenyx Pharmaceutical has reported Return on Equity [ROE] for 12 years.
- Annual Return on Equity [ROE] has declined for five consecutive years, with a five-year change of -636.51 percentage points (FY2020 to FY2025).
- The FY2025 figure stands as the lowest annual Return on Equity [ROE] in data going back to FY2014.
- Business Quant data shows RARE's Return on Equity [ROE] at -214.72% in FY2024 (-21.10 pp), -193.62% in FY2023 (-82.61 pp), -111.01% in FY2022 (-67.29 pp) and -43.72% in FY2021 (-23.08 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -723.80% |
| Jun 30, 2025 | -361.16% |
| Mar 31, 2025 | -275.35% |
| Dec 31, 2024 | -189.09% |
| Sep 30, 2024 | -143.56% |
| Jun 30, 2024 | -204.47% |
| Mar 31, 2024 | -295.58% |
| Dec 31, 2023 | -395.81% |
| Sep 30, 2023 | -790.43% |
| Jun 30, 2023 | -412.43% |
| Mar 31, 2023 | -251.21% |
| Dec 31, 2022 | -172.37% |
| Sep 30, 2022 | -118.24% |
| Jun 30, 2022 | -68.63% |
| Mar 31, 2022 | -54.71% |
| Dec 31, 2021 | -48.92% |
| Sep 30, 2021 | -37.31% |
| Jun 30, 2021 | -34.68% |
| Mar 31, 2021 | -18.44% |
| Dec 31, 2020 | -20.50% |
API Access
Ultragenyx Pharmaceutical Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();